Clinical Trial Update: Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema [Phase 3]

View source ↗

Summary

Phase 3 study of oral deucrictibant for on-demand treatment of hereditary angioedema attacks in adolescents and adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• Deucrictibant (Deucrictibant)

Snippet

Sponsor: Pharvaris Netherlands B.V. | Conditions: Hereditary Angioedema, Hereditary Angioedema Type I | Phase 3 | Status: COMPLETED